Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

346 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy.
Bonanno L, Costa C, Majem M, Sanchez JJ, Gimenez-Capitan A, Rodriguez I, Vergnenegre A, Massuti B, Favaretto A, Rugge M, Pallares C, Taron M, Rosell R. Bonanno L, et al. Among authors: sanchez jj. Oncotarget. 2013 Oct;4(10):1572-81. doi: 10.18632/oncotarget.1157. Oncotarget. 2013. PMID: 24197907 Free PMC article.
Targeted therapy in combination with gemcitabine in non-small cell lung cancer.
Rosell R, Crino L, Danenberg K, Scagliotti G, Bepler G, Taron M, Alberola V, Provencio M, Camps C, De Marinis F, Sanchez JJ, Peñas R. Rosell R, et al. Among authors: sanchez jj. Semin Oncol. 2003 Aug;30(4 Suppl 10):19-25. doi: 10.1016/s0093-7754(03)00281-1. Semin Oncol. 2003. PMID: 12917817 Review.
Effect of the methylenetetrahydrofolate reductase C677T polymorphism on patients with cisplatin/gemcitabine-treated stage IV non-small-cell lung cancer.
Alberola V, Sarries C, Rosell R, Taron M, de las Peñas R, Camps C, Massuti B, Insa A, Garcia-Gomez R, Isla D, Artal A, Muñoz MA, Cobo M, Bover I, Gonzalez-Larria JL, Terrasa J, Almenar D, Barcelo R, Diz P, Sanchez-Ronco M, Sanchez JJ. Alberola V, et al. Among authors: sanchez jj, sanchez ronco m. Clin Lung Cancer. 2004 May;5(6):360-5. doi: 10.3816/clc.2004.n.014. Clin Lung Cancer. 2004. PMID: 15217535 Clinical Trial.
Gene expression as a predictive marker of outcome in stage IIB-IIIA-IIIB non-small cell lung cancer after induction gemcitabine-based chemotherapy followed by resectional surgery.
Rosell R, Felip E, Taron M, Majo J, Mendez P, Sanchez-Ronco M, Queralt C, Sanchez JJ, Maestre J. Rosell R, et al. Among authors: sanchez jj, sanchez ronco m. Clin Cancer Res. 2004 Jun 15;10(12 Pt 2):4215s-4219s. doi: 10.1158/1078-0432.CCR-040006. Clin Cancer Res. 2004. PMID: 15217961 Clinical Trial.
BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer.
Taron M, Rosell R, Felip E, Mendez P, Souglakos J, Ronco MS, Queralt C, Majo J, Sanchez JM, Sanchez JJ, Maestre J. Taron M, et al. Among authors: sanchez jj, sanchez jm. Hum Mol Genet. 2004 Oct 15;13(20):2443-9. doi: 10.1093/hmg/ddh260. Epub 2004 Aug 18. Hum Mol Genet. 2004. PMID: 15317748
Clinical significance of hypoxia-inducible factor-1a messenger RNA expression in locally advanced non-small-cell lung cancer after platinum agent and gemcitabine chemotherapy followed by surgery.
Felip E, Taron M, Rosell R, Mendez P, Queralt C, Ronco MS, Sanchez JJ, Sanchez JM, Maestre J, Majo J. Felip E, et al. Among authors: sanchez jj, sanchez jm. Clin Lung Cancer. 2005 Mar;6(5):299-303. doi: 10.3816/clc.2005.n.009. Clin Lung Cancer. 2005. PMID: 15845181 Clinical Trial.
14-3-3sigma methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival: The Spanish Lung Cancer Group.
Ramirez JL, Rosell R, Taron M, Sanchez-Ronco M, Alberola V, de Las Peñas R, Sanchez JM, Moran T, Camps C, Massuti B, Sanchez JJ, Salazar F, Catot S; Spanish Lung Cancer Group. Ramirez JL, et al. Among authors: sanchez jj, sanchez jm, sanchez ronco m. J Clin Oncol. 2005 Dec 20;23(36):9105-12. doi: 10.1200/JCO.2005.02.2905. J Clin Oncol. 2005. PMID: 16361617
Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study.
Ramírez de Molina A, Sarmentero-Estrada J, Belda-Iniesta C, Tarón M, Ramírez de Molina V, Cejas P, Skrzypski M, Gallego-Ortega D, de Castro J, Casado E, García-Cabezas MA, Sánchez JJ, Nistal M, Rosell R, González-Barón M, Lacal JC. Ramírez de Molina A, et al. Among authors: sanchez jj. Lancet Oncol. 2007 Oct;8(10):889-97. doi: 10.1016/S1470-2045(07)70279-6. Lancet Oncol. 2007. PMID: 17851129
BRCA1: a novel prognostic factor in resected non-small-cell lung cancer.
Rosell R, Skrzypski M, Jassem E, Taron M, Bartolucci R, Sanchez JJ, Mendez P, Chaib I, Perez-Roca L, Szymanowska A, Rzyman W, Puma F, Kobierska-Gulida G, Farabi R, Jassem J. Rosell R, et al. Among authors: sanchez jj. PLoS One. 2007 Nov 7;2(11):e1129. doi: 10.1371/journal.pone.0001129. PLoS One. 2007. PMID: 17987116 Free PMC article.
346 results